BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rainero I, Martino PD, Pinessi L. Hypocretins and primary headaches: neurobiology and clinical implications. Expert Review of Neurotherapeutics 2014;8:409-16. [DOI: 10.1586/14737175.8.3.409] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Cargnin S, Sances G, Shin JI, Tassorelli C, Terrazzino S. Gene polymorphism association studies in cluster headache: A field synopsis and systematic meta-analyses. Headache 2021;61:1060-76. [PMID: 34309832 DOI: 10.1111/head.14168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 van Oosterhout WPJ, van Opstal AM, Schoonman GG, van der Grond J, Terwindt GM, Ferrari MD, Kruit MC. Hypothalamic functional MRI activity in the initiation phase of spontaneous and glyceryl trinitrate-induced migraine attacks. Eur J Neurosci 2021;54:5189-202. [PMID: 34197660 DOI: 10.1111/ejn.15369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Alstadhaug KB, Andreou AP. Caffeine and Primary (Migraine) Headaches-Friend or Foe? Front Neurol 2019;10:1275. [PMID: 31849829 DOI: 10.3389/fneur.2019.01275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
4 Papasavva M, Katsarou MS, Vikelis M, Mitropoulou E, Dermitzakis EV, Papakonstantinou S, Arvaniti C, Mitsikostas DD, Gozes I, Tsatsakis AM, Drakoulis N. Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population. J Mol Neurosci 2020;70:467-74. [PMID: 31768945 DOI: 10.1007/s12031-019-01439-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
5 Grafe LA, Bhatnagar S. Orexins and stress. Front Neuroendocrinol 2018;51:132-45. [PMID: 29932958 DOI: 10.1016/j.yfrne.2018.06.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 10.0] [Reference Citation Analysis]
6 Chieffi S, Carotenuto M, Monda V, Valenzano A, Villano I, Precenzano F, Tafuri D, Salerno M, Filippi N, Nuccio F, Ruberto M, De Luca V, Cipolloni L, Cibelli G, Mollica MP, Iacono D, Nigro E, Monda M, Messina G, Messina A. Orexin System: The Key for a Healthy Life. Front Physiol 2017;8:357. [PMID: 28620314 DOI: 10.3389/fphys.2017.00357] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 14.8] [Reference Citation Analysis]
7 Lambru G, Andreou AP, de la Torre ER, Martelletti P. Tackling the perils of unawareness: the cluster headache case. J Headache Pain 2017;18:49. [PMID: 28451865 DOI: 10.1186/s10194-017-0757-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Cady RJ, Denson JE, Sullivan LQ, Durham PL. Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization. Neuroscience 2014;269:79-92. [PMID: 24685439 DOI: 10.1016/j.neuroscience.2014.03.043] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
9 Rainero I, Rubino E, Paemeleire K, Gai A, Vacca A, De Martino P, Gentile S, Sarchielli P, Pinessi L. Genes and primary headaches: discovering new potential therapeutic targets. J Headache Pain 2013;14:61. [PMID: 23848401 DOI: 10.1186/1129-2377-14-61] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
10 Cady RJ, Shade CL, Cady RK. Advances in Drug Development for Acute Migraine: . Drugs 2012;72:2187-205. [DOI: 10.2165/11641120-000000000-00000] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
11 Poca MA, Galard R, Serrano E, Merino MA, Pozo-rosich P, Solana E, Mestres O, de la Calzada MD, Sahuquillo J. Normal Hypocretin-1 (Orexin A) Levels in Cerebrospinal Fluid in Patients with Idiopathic Intracranial Hypertension. Acta Neurochirurgica Supplementum 2012. [DOI: 10.1007/978-3-7091-0956-4_43] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
12 Rainero I, Rubino E, Gallone S, Fenoglio P, Picci LR, Giobbe L, Ostacoli L, Pinessi L. Evidence for an association between migraine and the hypocretin receptor 1 gene. J Headache Pain 2011;12:193-9. [PMID: 21344296 DOI: 10.1007/s10194-011-0314-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
13 Waeber C, Hargreaves R. Current and emerging therapies for migraine prevention and treatment. Handbook of Clinical Neurology 2010. [DOI: 10.1016/s0072-9752(10)97065-6] [Reference Citation Analysis]